BactiQuant A/S (9JX) Stock Statistics & Valuation Metrics

BactiQuant A/S has a market cap or net worth of €10.54M. The enterprise value is ―.

BactiQuant A/S has 37,521,854 shares outstanding. The number of shares has decreased by -2.65% in one year.

BactiQuant A/S’s return on equity (ROE) is -0.80 and return on invested capital (ROIC) is -48.44%.

The current PE Ratio of BactiQuant A/S is ―. BactiQuant A/S’s PEG ratio is ―.

In the last 12 months, BactiQuant A/S had revenue of 8.32M and earned -13.83M in profits. Earnings per share was -0.46.

In the last 12 months, operating cash flow was -11.49M and capital expenditures 0.00, giving a free cash flow of -11.49M billion.

BactiQuant A/S pays an annual dividend of ―, resulting in a dividend yield of ―

BactiQuant A/S upcoming earnings date is ―, ―.

BactiQuant A/S as a current ratio of 6.02, with Debt / Equity ratio of 57.94%

In the past 12 months, BactiQuant A/S has paid 0.00 in taxes.

BactiQuant A/S EV to EBITDA ratio is -7.38, with an EV/FCF ratio of -8.43.

BactiQuant A/S has €11.94M in cash and marketable securities with €9.35M in debt, giving a net cash position of €4.71M billion.

Gross margin is -7.02%, with operating margin of -150.52%, and net profit margin of -166.29%.

The average price target for BactiQuant A/S is ―, which is 11.43% higher than the current price. The consensus rating is ―